Presently, Richard G. Ghalie holds the position of Chief Medical Officer of MEI Pharma, Inc. Dr. Ghalie is also on the board of Viracta Subsidiary, Inc.

In his past career Dr. Ghalie occupied the position of VP-Clinical Research & Regulatory Affairs at Poniard Pharmaceuticals, Inc., VP-Medical Affairs & Professional Services at Ligand Pharmaceuticals, Inc., Chief Medical Officer for Novalar Pharmaceuticals, Inc., Chief Medical Officer at Denovo Biopharma LLC, Chief Medical Officer for Favrille, Inc., Chief Medical Officer at HemaQuest Pharmaceuticals, Inc., Senior Medical Director-Oncology Products at Immunex Corp. and Medical Director-Bone Marrow Transplant Center at Rush University Medical Center.

Dr. Ghalie received an MBA from the University of Washington, a doctorate from St. Joseph's College and a graduate degree from Université Paris Diderot-Paris 7.